Enero reports second half growth with strong agency momentum
Enero has reported its financial results for the twelve months ending 30 June 2025, indicating continued growth momentum across the group's agency portfolio and improved performance in the second half of the year.
Financial results
The group delivered year-on-year EBITDA growth of 2% from continuing operations in FY25. The group's Technology, Healthcare and Consumer (THC) Practise was a significant contributor, with EBITDA increasing by 0.2% over the previous year and margins showing notable improvement. The second half of the year was particularly strong, with THC Practise EBITDA up by 9% and net revenue rising by 2% compared to the first half.
Enero's Chief Executive Officer, Ian Ball, noted the impact of recent wins and industry recognition on the group's performance. He said:
"Our second half results show the strength of Enero's portfolio and our ability to adapt to shifting market dynamics. From landmark client wins to world-class recognition, our agencies have proven they can deliver both growth and industry-leading work. This momentum sets us up for good progress in FY26."
Agency performance
Hotwire Global, Enero's technology and communications consultancy, adapted to what was described as a challenging technology environment. During the second half of FY25, Hotwire rebranded its performance marketing operations globally under ROI·DNA. This strategic move raised Hotwire's market profile, achieving Google Premier Partner status and contributing to the acquisition of its first multi-regional client for the new financial year. The launch of Hotwire Global AI Lab was also highlighted, along with new industry accolades such as inclusion in PRNEWS' Agency Elite Top 120 and a gold award for Excellence in B2B Marketing at the Marketing Excellence Awards.
BMF, the group's creative agency, reported increased momentum in the second half following its largest ever client win with Westpac in February. This contributed to a successful year, with BMF securing four trophies at the Mumbrella Awards: Creative Agency of the Year, Award for Culture, Ad Campaign of the Year, and Account Management Team of the Year. Further industry recognition included being named Spikes Asia Strategy & Effectiveness Agency of the Year and Effective Agency of the Year at the Effies. Recent wins continued into the new financial year, with BMF winning HCF's creative account.
Orchard concluded the financial year with doubled EBITDA and 19% revenue growth in the second half compared to the first half. This growth was realised across both its healthcare and consumer business areas, supported by new drug launches, expanded healthcare services, and strong demand for CGI and adjacent consumer offerings. Orchard received additional recognition, being named Customer Choice Partner of the Year (ANZ) at the Optimizely Awards and becoming the most awarded agency at the Prime Healthcare Awards, including Marketing Campaign of the Year. Orchards' new business wins included brands such as Abbvie, Detmold Group, and Boehringer Ingelheim.
Strategic focus
Diversification of the agency portfolio continued, with the sale of OBMedia. This transaction has sharpened the business's focus on its core agency operations.
Ian Ball commented on the direction for the year ahead:
"As we enter FY26 with a more defined portfolio and an exclusive focus on our award-winning agencies - BMF, Hotwire, ROI·DNA and Orchard - our focus is firmly on building the next chapter of growth for Enero. Each agency has strong leadership, vision, capabilities and a track record of delivering outstanding results for clients. That focus on differentiation and innovation provides a solid foundation to create long-term value for clients, attract top talent and deliver strong returns for shareholders."
